Diagnostics Innovation Biotech Environment Testing Research Diagnostics Innovation Biotech
Diagnostics Innovation Biotech Environment Testing Research Diagnostics Innovation Biotech

We partner with investors, startups, VCs, and banks to deliver end‑to‑end pharmaceutical and healthcare ventures — from greenfield facility plans to product development, regulatory approvals, and launch.

Our turn‑key model covers RFP and vendor/CDMO selection, site visits and negotiations, technology transfer, quality systems, clinical and regulatory strategy, and market access — providing a single accountable partner.

What We Deliver for Investors

Comprehensive turn‑key execution across facilities, products, and compliance — aligned with regional and global requirements.

  • Pharmaceutical facility development (API, finished product, excipients) — GMP‑compliant design.
  • Product development across pharmaceuticals, nutraceuticals, and cosmeceuticals.
  • Regulatory affairs across DRAP, FDA, EMA, MHRA, GHC , MENA and SFDA.
  • Market research, competitive analysis, licensing, and partnerships.
  • Clinical trials coordination and compliance support.
  • RFP management, vendor/CDMO shortlisting, site visits, and negotiations.
  • Technology Transfer: Methods, Materials, Processes, and Documentation.

RFP & Vendor Selection

Define scope, issue RFPs, compare proposals, and shortlist CDMOs/CROs using cost, quality, and compliance criteria.

Site Visits & Negotiation

Coordinate 2–3 site visits, evaluate capabilities, negotiate contracts, and select primary and backup partners.

Technology Transfer & Launch

Transfer methods, materials, and processes; stand up QMS; and prepare regulatory and market access packages.

Our Approach

A single accountable partner from feasibility to launch — integrating technical, regulatory, financial, and operational workstreams.

  • Transparent governance: milestones, KPIs, and risk registers.
  • Vendor oversight with audits, change control, and quality gates.

Execution & Compliance

Stand up operations with Qualified Partners, Technology Transfer packs, and Regulatory submissions per market.

Vendor/CDMO

Clear guidance, negogiation support and qualification.

Investor Partnerships & Delivery Network

We leverage a network of CDMOs, CROs, clinical sites, and healthcare builders to deliver compliant, cost‑effective projects.

Facility Development

cGMP‑compliant API, finished product, and excipient plants with validation plans.

Product & Regulatory

Development plans, licensing/partnerships, and filings across DRAP, FDA, EMA, MHRA, GHC, MENA and SFDA.

Healthcare Build‑Out

Hospitals, Clinics, Diagnostics, Pharmacy Chains, Accreditation (ISO/JCI/NABH), and QMS.

Frequently asked questions about Turn‑Key Consultancy

Facility development, product development, regulatory affairs, market research, licensing/partnerships, clinical coordination, and compliance.

We run structured RFPs, shortlist vendors, conduct site visits, negotiate, and manage delivery with KPIs and quality gates.

Yes — we coordinate filings and responses across DRAP, FDA, EMA, MHRA, SFDA, MENA and GHC regulators.

We plan and deliver Hospitals, Clinics, Diagnostic Labs, and Pharmacy Chains, including ISO/JCI/NABH Accreditation programs.

Yes — we provide asset evaluation, risk/gap analysis, capital estimates, and tracking for investor/bank decision‑making.